Predict your next investment

Koye Pharmaceuticals company logo
HEALTHCARE | Drug Manufacturing / Generics
koye.co

See what CB Insights has to offer

Founded Year

2013

Stage

Debt | Alive

Total Raised

$14.09M

Last Raised

$4.09M | 1 yr ago

About Koye Pharmaceuticals

Koye Pharmaceuticals is a specialty pharmaceutical company that is focused on the manufacturing and selling of Indian branded pharmaceuticals with operations across India.

Koye Pharmaceuticals Headquarter Location

A-10, Art Guild House, Phoenix Market City Annexe, LBS Marg

Maharashtra, 400070,

India

+91 22 68661200

Latest Koye Pharmaceuticals News

PremjiInvest-backed Koye Pharmaceuticals raises debt capital

Sep 2, 2020

By SHARE Mumbai-based Koye Pharmaceuticals Pvt. Ltd has raised debt capital from non-banking financial company BlackSoil Capital Pvt. Ltd. Blacksoil said in a statement it has extended Rs 30 crore ($4.11 million) to Koye. The pharmaceuticals company will use the funds to boost its position in the domestic formulation market and meet its working capital needs. In November 2018, Koye had attracted funding from PremjiInvest, the family office of Wipro Ltd founder-chairman Azim Premji. This was PremjiInvest’s first bet on a pharmaceutical company in the country in more than a decade. The financial details of the transaction were not disclosed but VCCircle had reported then that PremjiInvest was set to invest Rs 125-130 crore (about $18 million) in Koye for a stake of around 15%. Koye, which makes essential drugs for primary speciality care, was founded in 2013 by Ravindra Shenoy and Preetish Toraskar. It had first raised external capital from multi-stage investor Sequoia Capital the same year. Sequoia put more money into the company in 2017, increasing its stake from 58.3% to 62.6%. The venture capital and growth-stage investor has invested a total of $28.76 million in the company in various tranches, according to VCCEdge, the data research platform of Mosaic Digital. Koye has also previously raised money from Temasek’s venture debt arm, InnoVen Capital. BlackSoil, which offers debt to real estate developers and unlisted and new-age companies, has disbursed over Rs 1,600 crore across over 90 deals since its inception in 2016. Some of its key startup investments include Oyo Rooms, EarlySalary, Chumbak, Lets Transport, Vogo and Rentomojo. Last week, BlackSoil raised Rs 25 crore ($3.35 million) by issuing non-convertible debentures (NCDs). This was the third NCD issue by the company since January, raising Rs 75 crore in total from over 100 investors.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Koye Pharmaceuticals

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Koye Pharmaceuticals is included in 1 Expert Collection, including Pharma Startups.

P

Pharma Startups

6,549 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

Koye Pharmaceuticals Patents

Koye Pharmaceuticals has filed 5 patents.

The 3 most popular patent topics include:

  • Community websites
  • Graphical control elements
  • Graphical user interface elements
patents chart

Application Date

Grant Date

Title

Related Topics

Status

7/23/2019

4/13/2021

Graphical user interface elements, Graphical user interfaces, Graphical control elements, Graphical user interface testing, User interfaces

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

7/23/2019

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

4/13/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Graphical user interface elements, Graphical user interfaces, Graphical control elements, Graphical user interface testing, User interfaces

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Koye Pharmaceuticals Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Koye Pharmaceuticals Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.